spacer
home > pmps > summer 2007 > cold chain control
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Cold Chain Control

Increasing legislation surrounding the cold chain storage and shipping of pharmaceuticals means that manufacturers and suppliers need to be more diligent than ever. Geraint Thomas of Laminar Medica assesses the latest generation of temperature-controlled packaging solutions

With pharmaceuticals and related products being distributed over increasingly long distances and through extreme temperature zones, the benefits of sophisticated temperature-controlled packaging solutions have become clear to drug manufacturers and suppliers. Shipments that reach temperatures outside of their acceptable limits often need to be recalled, leading to considerable losses and irreparable damage to valuable client relationships and the distributor’s reputation. In addition to enabling these risks to be minimised, the latest temperature controlled packaging solutions are helping pharmaceutical companies to comply with the growing amount of regulations and legislation now being introduced to ensure the safety and security of the storage and distribution of temperature sensitive drugs.

NEW REGULATIONS

A number of regulations and guidelines relating to the cold chain distribution of pharmaceuticals can now be found in pharmacopoeia and other publications such as The Guide to Good Storage Practice for Pharmaceuticals and The Guidelines on Good Distribution Practice (GDP) of Medicinal Products. These documents contain information on the latest legislation relating to the shipping of temperature-sensitive drugs, detailing the need for effective and standardised packaging and labelling for products, traceable and efficient dispatch processes, and the use of temperature recording devices to determine accurately whether a package has stayed within its acceptable temperature parameters.

According to documents produced by the European Medicines Evaluation Agency (EMEA), it is essential for the safe and secure distribution of pharmaceuticals that subjective terms such as ‘ambient conditions’, ‘room temperature’ and ‘cold’ in product storage and distribution guidelines are replaced with more accurate instructions relating to the acceptable conditions for drugs, and how to act should this environment not be maintained. For a more focused and regulated approach to storing and transporting drugs to be achieved, new and more sophisticated distribution systems are required to ensure that these tighter controls can be maintained.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Geraint Thomas graduated from Brunel University in 1996 with a BSc (first class honours) in Industrial Product Design. After working as a Board Game Engineer for Hasbro toys, he joined Laminar Medica in 1998 as a Packaging Development Technologist with responsibility for packaging solutions and qualification packages for insulated shipper design. Now employed as Technical Director, Geraint has been instrumental in realising Laminar Medica’s development programme, including the expansion of the company’s qualification laboratory and R&D facility.
spacer
Geraint Thomas
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Smart Bioprocessing with the new Eppendorf Control System

Hamburg, February 12, 2020 Working with flexible systems that evolve with the changing needs in a lab is indispensable. With the SciVario twin, Eppendorf, a key life science company, introduces its latest bioreactor control system for small- and bench-scale applications. The intelligent controller and new, innovative bay-drawer system enables the exchange of standardized modules to flexibly adapt the controller to the changing requirements in a laboratory.
More info >>

White Papers

Antibody Internalization: Advanced Flow Cytometry and Live-Cell Analysis Give Rich Insights During Antibody Profiling

Sartorius Group

The natural characteristics of antibodies, such as high binding affinity, specificity to a wide variety of targets, and good stability, make them ideal therapeutic candidates for many diseases. Monoclonal antibodies (mAbs), in particular, deliver promising therapeutic results in several different disease areas, such as autoimmunity, oncology, and chronic inflammation. Researchers’ abilities to improve the breadth of antibodies have been aided by innovative technologies for antibody discovery, for instance, through humanization of mouse antibodies and phage display. However, advanced antibody design techniques create the need for new screening methods so that lead candidates can be quickly and effectively identified as early in the development process as possible.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement